High Analyst Price Target: Beware The Conflicts of Interest
- The most quoted piece of information from analyst reports also happens to be the most useless. Price targets should be taken with a grain of … Continue Reading
Read now- The most quoted piece of information from analyst reports also happens to be the most useless. Price targets should be taken with a grain of … Continue Reading
Read now- New drugs are expensive and time-consuming to develop and market. Some studies estimate that the cost of bringing a drug to market—from R&D to FDA … Continue Reading
Read now- Generic pharmaceuticals are drug products designed to be functionally identical (bioequivalent) to brand name drugs in terms of the active ingredient, dosage strengths, forms, indications, … Continue Reading
Read now- One of the primary reasons that private companies go public is to lower the cost and increase the efficiency of raising additional capital. However, investors who … Continue Reading
Read now- Raising capital often carries positive implications for a company’s shareholders, enabling growth & acquisitions, for example, and may be accretive in the long run. But financings … Continue Reading
Read now